Dentsply Sirona Inc. (XRAY)

51.13
NASDAQ : Health Technology
Prev Close 49.90
Day Low/High 49.51 / 51.21
52 Wk Low/High 33.93 / 59.40
Avg Volume 1.66M
Exchange NASDAQ
Shares Outstanding 224.18M
Market Cap 11.19B
EPS -4.50
P/E Ratio 115.95
Div & Yield 0.40 (0.70%)

Latest News

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Finding the stocks that have changed direction.

Women Are Still Severely Underrepresented in Corporate America

Women Are Still Severely Underrepresented in Corporate America

Women occupy just one out of five board seats at S&P 500 companies.

Jim Cramer on Why a Company's Gender Diversity Matters for Investor

Jim Cramer on Why a Company's Gender Diversity Matters for Investor

TheStreet’s Jim Cramer says investors should be a little bit more circumspect of companies that don’t promote women or have them on their boards.

Dentsply upgraded at William Blair

Here's Where to Invest When the Fed Pulls the Trigger

Consolidating industries means expanding gross margins.

Dentsply upgraded at Baird

Market Wrap: Gains Extend Far and Wide

Fed's 2-day meeting starts Wednesday.

Investing in the Retirement Crisis

Investing in the Retirement Crisis

Some companies in better position than aging population.

Dentsply downgraded at Baird

Cramer: Stocks That Stand Out

There's a powerful collection of "what's working."

Profit From the Longer Life Spans, Part 1

Profit From the Longer Life Spans, Part 1

Americans are living much longer these days -- and there are a number of ways to invest.

Dentsply downgraded at Goldman

Invest in Longevity

Invest in Longevity

Consider this unsexy but good value play in healthcare. 

Dentsply upgraded at Goldman

Dentsply upgraded at BofA/Merrill

A Dent in Dentsply

The company missed EPS expectations and guided lower. Dentsply (XRAY), a competitor to Henry Schein (HSIC), misses and guides year lower. The company sees the fiscal year's EPS at $2.33-$2.43, down from previous forecast. First-quarter earnings were...

Dentsply downgraded at UBS